These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26093494)

  • 21. Modeling of [
    Schildt A; de Vries EFJ; Willemsen ATM; Moraga-Amaro R; Lima-Giacobbo B; Sijbesma JWA; Sossi V; Dierckx RAJO; Doorduin J
    Mol Imaging Biol; 2020 Aug; 22(4):931-939. PubMed ID: 31907846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.
    Kudo Y; Okamura N; Furumoto S; Tashiro M; Furukawa K; Maruyama M; Itoh M; Iwata R; Yanai K; Arai H
    J Nucl Med; 2007 Apr; 48(4):553-61. PubMed ID: 17401091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal Trajectory and Progression Score Estimation from Voxelwise Longitudinal Imaging Measures: Application to Amyloid Imaging.
    Bilgel M; Jedynak B; Wong DF; Resnick SM; Prince JL
    Inf Process Med Imaging; 2015; 24():424-36. PubMed ID: 26221692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
    Lopresti BJ; Klunk WE; Mathis CA; Hoge JA; Ziolko SK; Lu X; Meltzer CC; Schimmel K; Tsopelas ND; DeKosky ST; Price JC
    J Nucl Med; 2005 Dec; 46(12):1959-72. PubMed ID: 16330558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
    Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O;
    Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic modeling of [
    Jin H; Yue X; Liu H; Han J; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z
    J Neurochem; 2018 Mar; 144(6):791-804. PubMed ID: 29315563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
    Price JC; Klunk WE; Lopresti BJ; Lu X; Hoge JA; Ziolko SK; Holt DP; Meltzer CC; DeKosky ST; Mathis CA
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1528-47. PubMed ID: 15944649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease.
    Cui M; Ono M; Kimura H; Ueda M; Nakamoto Y; Togashi K; Okamoto Y; Ihara M; Takahashi R; Liu B; Saji H
    J Med Chem; 2012 Nov; 55(21):9136-45. PubMed ID: 22690944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer's disease.
    Tuszynski T; Rullmann M; Luthardt J; Butzke D; Tiepolt S; Gertz HJ; Hesse S; Seese A; Lobsien D; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1077-87. PubMed ID: 26739328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling Strategies for Quantification of In Vivo
    Hahn A; Schain M; Erlandsson M; Sjölin P; James GM; Strandberg OT; Hägerström D; Lanzenberger R; Jögi J; Olsson TG; Smith R; Hansson O
    J Nucl Med; 2017 Apr; 58(4):623-631. PubMed ID: 27765859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.
    Kepe V; Huang SC; Small GW; Satyamurthy N; Barrio JR
    Methods Enzymol; 2006; 412():144-60. PubMed ID: 17046657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosynthesis and in vivo evaluation of a ¹⁸F-labelled styryl-benzoxazole derivative for β-amyloid targeting.
    Ribeiro Morais G; Gano L; Kniess T; Bergmann R; Abrunhosa A; Santos I; Paulo A
    Appl Radiat Isot; 2013 Dec; 82():100-4. PubMed ID: 23974304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
    Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
    Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
    Bourgeat P; Chételat G; Villemagne VL; Fripp J; Raniga P; Pike K; Acosta O; Szoeke C; Ourselin S; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Salvado O;
    Neurology; 2010 Jan; 74(2):121-7. PubMed ID: 20065247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.